JUN 12, 2018 7:35 AM PDT

CD44 Insights & Cancer Influence

WRITTEN BY: Mauri Brueggeman

The molecule called CD44 is a transmembrane glycoprotein involved in cell to cell adhesion, interactions, and signaling.  It is also a receptor of hyaluronic acid (HA) which is mechanistically involved in cell adhesion, cellular migration, survival, and cell proliferation.  The letters “CD” stand for “cluster of differentiation” which mean this protein is part of a large family of cell surface molecules expressed by cells for a particular purpose.  Some CD proteins are specific for a single cell type but most often, CD molecules are found on multiple cell types within the body. These surface proteins are used as “markers” for scientists and providers to provide information about cellular involvement in diseases such as cancer.

CD44 is not just a single unique surface marker.  It is found to be overexpressed in many cancers which contribute to their ability to proliferate and spread.  While there is information in the literature about CD44 and the cellular biology related to its processes, signaling pathways, gene sequence, expression, and action in the body, there is still much that is not well understood.  There are groups researching this particular transmembrane glycoprotein because of the potential connection it could have as a therapeutic target for cancer immunotherapy. 

The gene for CD44 is located on chromosome 11, specifically 11p13, in humans.  Interestingly in mice, this gene is located on chromosome 2.  The CD44 gene in humans has 19 exons with the first and last 5 exons being identical.  Expression of this gene results in a protein with multiple variants based on the combination of spliced exons involved beyond the 10 identical sequences flanking either end.  The molecular protein structure of CD44 includes binding motifs that are altered based on the expressed spliced variants.  CD44 variants with altered binding motifs promote increased interaction within the cellular environment and the structural protein changes create co-receptor opportunities for growth factors and protection from destruction by the immune system.  CD44 is believed to promote tumorigenesis and is already used as a molecular marker for cancer cell identification.  CD44 is found on stem cells and CD44 variants, or isoforms, maintain a malignant cell’s “stemness” characteristics, thus furthering tumor proliferation, cellular replication, and malignant cell growth. 

Current research focuses on approaches including: neutralization of CD44 through the use of antibodies, introduction of short hairpin RNAs (shRNA) which silence gene expression through RNA interference, introduction of ectodomain blocking molecules specific to CD44 variants, and a few others. 

A recent publication in the Journal of Hematology Oncology outlines the significance and role of CD44 in cancers and includes details about the multitude of variants or CD44 isoforms involved in progression of specific cancer types based on current literature available. 

Source: Journal of Hematology Oncology, NIH-US National Library of Medicine, Introductory Immunology, The Jackson Laboratory MGI, Labome, Stem Cells and Translational Medicine Journal,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
SEP 06, 2021
Drug Discovery & Development
Antibiotics Increase Colon Cancer Risk by 17%
SEP 06, 2021
Antibiotics Increase Colon Cancer Risk by 17%
People who take antibiotics are at an increased risk of developing colon cancer within five to ten years. The research w ...
SEP 16, 2021
Technology
Scientists Create Tiny Replicas Of The Pancreas To Study New Drugs
SEP 16, 2021
Scientists Create Tiny Replicas Of The Pancreas To Study New Drugs
Pancreatic cancer it’s often hard to diagnose in its early stages, resulting in patients having more advanced canc ...
SEP 23, 2021
Immunology
Enhanced Hamster Cells as Super Drug Factories
SEP 23, 2021
Enhanced Hamster Cells as Super Drug Factories
Antibodies are highly specialized proteins produced by the immune system that stick on to foreign invaders in the body w ...
OCT 09, 2021
Cell & Molecular Biology
The Anti-Cancer, Copper-Binding Compounds Found in Fish
OCT 09, 2021
The Anti-Cancer, Copper-Binding Compounds Found in Fish
In the world's waterways, fish are confronted with endless challenges. For example, they have to defend themselves from ...
OCT 25, 2021
Cell & Molecular Biology
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
OCT 25, 2021
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
Labroots virtual events are a great place to share research and learn about others work. These events feature participan ...
NOV 22, 2021
Cancer
A New Treatment Option for Patients with Cancer in the Eye
NOV 22, 2021
A New Treatment Option for Patients with Cancer in the Eye
Uveal melanoma (UM) is a rare malignancy characterized by the formation of cancer cells in the tissues of the eye. UM be ...
Loading Comments...